EUVIMEDEUVIMED entdecken
Crossref

Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma

Xiangqian Xu, Jun Zhang, Tangie Yao, Xiaokai Zhao, Qingyuan Wu, Chenghua Lu, Xiaoyan Guo, Shiyun Xie, Lei Qiu, Rongrong Bi, Honghao Xue

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xiangqian Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Gene Expression Regulation, Neoplastic, Carcinoma, Squamous Cell, Cadherins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), subtypes of non-small cell lung cancer (NSCLC), exhibit distinct characteristics. The expression and prognostic significance of Protocadherin Gamma Subfamily A, 12 (PCDHGA12) in NSCLC remain unexplored. This study analyzed transcriptomic and genomic datasets from TCGA to investigate PCDHGA12 expression and its prognostic relevance in LUAD and LUSC. We found PCDHGA12 mRNA and protein levels were downregulated in both LUAD and LUSC tissues compared to adjacent non-cancerous tissues, with high PCDHGA12 expression correlating with lower overall survival in LUSC but not in LUAD. GSEA revealed a unique enrichment pattern associated with PCDHGA12 low expression in LUSC, especially in the DNA repair pathway. Co-expression analysis showed associations of PCDHGA12 with focal adhesion and the PI3K-AKT pathway in LUAD, and additionally with ECM-receptor interaction in LUSC. Hub gene prognosis analysis identified genes correlated with prognosis only in LUSC, reflecting PCDHGA12's influence. Mutation analysis linked with PCDHGA12 identified differential mutations in SPTA1, KEAP1, and TNR in LUAD, and a notable NAV3 mutation in LUSC. Additionally, immuno-infiltration analysis reveals a positive correlation between PCDHGA12 expression and immune cell infiltration. Specifically, lower PCDHGA12 expression in LUSC is associated with higher levels of CD8 T cells and DCs, lower levels of Tregs and M0 macrophages, and increased expression of HMGB1 and TNFRSF18. These genetic and immunological differences may account for the significant prognostic disparity of PCDHGA12 levels between LUAD and LUSC. Further experimental studies are essential to validate these associations and investigate potential targeted and immunotherapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsGene Expression Regulation, NeoplasticCarcinoma, Squamous CellCadherinsAdenocarcinoma of LungHumansPrognosisBiomarkers, TumorMutationMaleCarcinoma, Non-Small-Cell LungFemale

Stichwörter der Autor:innen

Immune infiltrationMutation analysisNSCLCPCDHGA12Prognosis

Substanzen

CadherinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pulmonology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
  • Department of R&D, Zhejiang Yunying Medical Technology Co., Ltd., Jiaxing 314006, China.
  • Department of Pulmonology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China. Electronic address: lh2561@shutcm.edu.cn.

Zitieren

APA

Xu, X., Zhang, J., Yao, T., Zhao, X., Wu, Q., Lu, C., Guo, X., Xie, S., Qiu, L., Bi, R., & Xue, H. (2024). Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112727

Vancouver

Xu X, Zhang J, Yao T, Zhao X, Wu Q, Lu C, et al. Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112727

BibTeX
@article{Xu2024,
  author = {Xu, Xiangqian and Zhang, Jun and Yao, Tangie and Zhao, Xiaokai and Wu, Qingyuan and Lu, Chenghua and Guo, Xiaoyan and Xie, Shiyun and Qiu, Lei and Bi, Rongrong and Xue, Honghao},
  title = {Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112727}
}
Kostenlos starten →